Evidence map›Paper›PMID 36326715›Full record

ReviewVirulence2022

Pathogenicity and virulence of

Mariko Sugawara-Mikami, Kazunari Tanigawa, Akira Kawashima, Mitsuo Kiriya, Yasuhiro Nakamura, Yoko Fujiwara, Koichi Suzuki

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Virulence, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed, 3 pooled it
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 3 syntheses or guidelines pooled it, 64 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Unraveling Drug Resistance inInternational journal of microbiology · 2025
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Mariko Sugawara-MikamiDepartment of Clinical Laboratory Science, Faculty of Medical Technology, Teikyo University, Tokyo, Japan.
Kazunari TanigawaDepartment of Molecular Pharmaceutics, Faculty of Pharma-Science, Teikyo University, Tokyo, Japan.
Akira KawashimaDepartment of Clinical Laboratory Science, Faculty of Medical Technology, Teikyo University, Tokyo, Japan.
Mitsuo KiriyaDepartment of Clinical Laboratory Science, Faculty of Medical Technology, Teikyo University, Tokyo, Japan.
Yasuhiro NakamuraDepartment of Molecular Pharmaceutics, Faculty of Pharma-Science, Teikyo University, Tokyo, Japan.
Yoko FujiwaraDepartment of Clinical Laboratory Science, Faculty of Medical Technology, Teikyo University, Tokyo, Japan.
Koichi SuzukiDepartment of Clinical Laboratory Science, Faculty of Medical Technology, Teikyo University, Tokyo, Japan.
Teikyo University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leprosy is caused by

Indexed as

LeprosyMycobacterium lepraeAnimalsDrug Therapy, CombinationLeprostatic AgentsVirulenceLeprostatic AgentsLeprosylipids metabolismmacrophageMycobacterium lepraepseudogeneSchwann cell

Identifiers

PMID36326715
PMCPMC9635560
OpenAlexW4308026468

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.